Century Therapeutics, Inc.
IPSC
Last
$1.47
Day
+0.7%
1y
+144.6%
5y
-93.5%
52w
-52.0%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1233d
EMA 21
1.65
EMA 50
1.84
EMA 200
1.87
20d high
-29.1%
5y high
-94.3%
5y range
4th
Positions held
Your positionsIPSC isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.71
Stop
$1.26
Stop distance
14.3%
Target vs last
+16.3%
Fundamentals
| Market cap | $264.37M | Enterprise value | $183.32M | Trailing P/E | — | Forward P/E | -3.24 |
| PEG | — | Price / book | 1.13 | Beta | 1.67 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -49.7% | ROA | -23.5% | Debt / equity | 0.17 |
| Current ratio | 8.28 | Free cash flow | -$50.41M | Analyst recommendation | buy | Mean target | $4.75 |
| 52w high | $3.04 | 52w low | $0.44 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$34.5M | -$21.6M | -$19.2M | -$34.4M | -$32.5M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$25.4M | -$23.7M | -$20.7M | -$29.4M | -$34.7M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $109M | $6.6M | $2.2M | $5.2M | — |
| Op margin | -9.6% | -2030.8% | -5600.9% | -2381.8% | — |
| Net income | -$9.6M | -$127M | -$137M | -$131M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$10.5M | -$134M | -$125M | -$124M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsIPSC · daily-22.8% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin